Nothing Special   »   [go: up one dir, main page]

Yu‐Wai‐Man et al., 2016 - Google Patents

A multiple sclerosis‐like disorder in patients with OPA1 mutations

Yu‐Wai‐Man et al., 2016

View PDF @Full View
Document ID
4513903975032233715
Author
Yu‐Wai‐Man P
Spyropoulos A
Duncan H
Guadagno J
Chinnery P
Publication year
Publication venue
Annals of clinical and translational neurology

External Links

Snippet

We describe three unrelated patients presenting with a spinal cord syndrome and neuroimaging features consistent with multiple sclerosis (MS). All harbored a pathogenic OPA1 mutation. Although the neurological phenotype resembled neuromyelitis optica …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Similar Documents

Publication Publication Date Title
Yu‐Wai‐Man et al. A multiple sclerosis‐like disorder in patients with OPA1 mutations
Fortea et al. Alzheimer's disease associated with Down syndrome: a genetic form of dementia
Edmonds et al. Subtle cognitive decline and biomarker staging in preclinical Alzheimer’s disease
Zakharov et al. Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients
Edmonds et al. “Missed” mild cognitive impairment: High false-negative error rate based on conventional diagnostic criteria
Zhang et al. Midlife lipid and glucose levels are associated with Alzheimer's disease
Bangen et al. Cortical amyloid burden differences across empirically-derived mild cognitive impairment subtypes and interaction with APOE ɛ4 genotype
Chabriat et al. CADASIL: yesterday, today, tomorrow
Tortelli et al. Midlife metabolic profile and the risk of late-life cognitive decline
Sivera et al. Phenotypical features of the p. R120W mutation in the GDAP1 gene causing autosomal dominant Charcot‐Marie‐Tooth disease
Buchman et al. Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons
Eyre et al. Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome
Kepp et al. The anti-amyloid monoclonal antibody lecanemab: 16 cautionary notes
Deik et al. Compound heterozygous PNPLA6 mutations cause Boucher–Neuhäuser syndrome with late-onset ataxia
Rebelo et al. Biallelic loss-of-function variations in PRDX3 cause cerebellar ataxia
Chang et al. Mortality risk after diagnosis of early-onset Alzheimer’s disease versus late-onset Alzheimer’s disease: a propensity score matching analysis
Paudel et al. Neuropathological features of genetically confirmed DYT1 dystonia: investigating disease-specific inclusions
Phyo et al. The utility of assessing health-related quality of life to predict cognitive decline and dementia
Alhajraf et al. Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta‐analyses
Lu et al. Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
Panza et al. Disease-modifying therapies for tauopathies: agents in the pipeline
Carcelén‐Gadea et al. Functional and structural changes in the visual pathway in multiple sclerosis
McQuilten et al. Effect of low-dose aspirin versus placebo on incidence of anemia in the elderly: a secondary analysis of the aspirin in reducing events in the elderly trial
Kardys et al. Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis
Kloth et al. Novel likely pathogenic variants in TMEM126A identified in non-syndromic autosomal recessive optic atrophy: two case reports